End-of-life cost and its determinants for cancer patients in urban China: a population-based retrospective study

被引:23
作者
Li, Zhong [1 ]
Pan, Zijing [1 ]
Zhang, Liang [1 ]
He, Ruibo [1 ]
Jiang, Shan [2 ]
Xu, Chengzhong [3 ]
Lu, Fangfang [3 ]
Zhang, Pei [3 ]
Li, Boyang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Hubei, Peoples R China
[2] Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing, Jiangsu, Peoples R China
[3] Yichang Ctr Dis Control & Prevent, Yichang, Peoples R China
来源
BMJ OPEN | 2019年 / 9卷 / 03期
基金
中国国家自然科学基金;
关键词
HEALTH-CARE UTILIZATION; LAST; 6; MONTHS; ADMINISTRATIVE DATA; PALLIATIVE CARE; INDICATORS; QUALITY; EXPENDITURES; INTENSITY; BURDEN; DEATH;
D O I
10.1136/bmjopen-2018-026309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study aimed to define the end-of-life (EOL) healthcare utilisation and its cost and determinants for cancer patients and to proactively inform related strategies in mainland China. Design A population-based retrospective study. Setting and participants Data from 894 cancer patients were collected in urban Yichang, China from 01 July 2015 to 30 June 2017. Outcome measures Emergency department (ED) visits, outpatient and inpatient hospitalisation services, intensive care unit (ICU) admission and total costs were used as the main outcomes. Results In this study, 66.8% of the 894 patients were male, and the average age was 60.4 years. Among these patients, 37.6% died at home, and patients had an average of 4.86 outpatient services, 2.23 inpatient hospitalisation services and 1.44 ED visits. Additionally, 5.9% of these patients visited the ICU at least once. During the EOL periods, the costs in the last 6 months, 3 months, 1 month and 1 week were US$ 18 234, US$ 13 043, US$ 6349 and US$ 2085, respectively. The cost increased dramatically as death approached. The estimation results of generalised linear regression models showed that aggressive care substantially affected expenditure. Patients with Urban Employee Basic Medical Insurance spent more than those with Urban Resident-based Basic Medical Insurance or the New Rural Cooperative Medical Scheme. The place of death and the survival time are also risk factors for increased EOL cost. Conclusion The findings suggested that the EOL cost for cancer patients is associated with aggressive care, insurance type and survival time. Timing palliative care is urgently needed to address ineffective and irrational healthcare utilisation and to reduce costs. Ethics and dissemination This study was approved by the Ethics Committee of the Tongji Medical College, Huazhong University of Science and Technology (IORG No.: IORG0003571). All the data used in this study were deidentified.
引用
收藏
页数:7
相关论文
共 50 条
[21]   Are family physician visits and continuity of care associated with acute care use at end-of-life? A population-based cohort study of homecare cancer patients [J].
Almaawiy, Ummukulthum ;
Pond, Gregory R. ;
Sussman, Jonathan ;
Brazil, Kevin ;
Seow, Hsien .
PALLIATIVE MEDICINE, 2014, 28 (02) :176-183
[22]   Association between palliative care and end-of-Life care for patients with hematological malignancies A population-based study [J].
Chiang, Jui-Kun ;
Lee, Yang-Cheng ;
Kao, Yee-Hsin .
MEDICINE, 2019, 98 (40)
[23]   Quality of end-of-life care in patients with dementia compared to patients with cancer: A population-based register study [J].
Martinsson, Lisa ;
Lundstrom, Staffan ;
Sundelof, Johan .
PLOS ONE, 2018, 13 (07)
[24]   Early referral to a palliative team improves end-of-life care among gynecological cancer patients: a retrospective, population-based study [J].
Paulsen, Torbjorn ;
Liland, Heidi ;
Myklebust, Tor Age ;
Lindemann, Kristina .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (02) :181-188
[25]   Inappropriate end-of-life cancer care in a generalist and specialist palliative care model: a nationwide retrospective population-based observational study [J].
Boddaert, Manon S. ;
Pereira, Chantal ;
Adema, Jeroen ;
Vissers, Kris C. P. ;
van der Linden, Yvette M. ;
Raijmakers, Natasja J. H. ;
Fransen, Heidi P. .
BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (E1) :E137-E145
[26]   Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study [J].
Lapeyre-Prost, Alexandra ;
Perkins, Geraldine ;
Vallee, Marie ;
Pozet, Astrid ;
Tougeron, David ;
Maillet, Marianne ;
Locher, Christophe ;
Dreanic, Johann ;
Legoux, Jean-Louis ;
Lievre, Astrid ;
Lecaille, Cedric ;
Sabate, Jean-Marc ;
Mary, Florence ;
Bonnetain, Franck ;
Jaulmes-Bouillot, Helene ;
Behal, Florence ;
Landi, Bruno ;
Taieb, Julien .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
[27]   High-Intensity End-of-Life Care Among Patients With GI Cancer in Puerto Rico: A Population-Based Study [J].
Ortiz-Ortiz, Karen J. ;
Tortolero-Luna, Guillermo ;
Torres-Cintron, Carlos R. ;
Zavala-Zegarra, Diego E. ;
Gierbolini-Bermudez, Axel ;
Ramos-Fernandez, Maria R. .
JCO ONCOLOGY PRACTICE, 2021, 17 (02) :E168-E177
[28]   Benchmarking time to initiation of end-of-life homecare nursing: a population-based cancer cohort study in regions across Canada [J].
Seow, Hsien ;
Qureshi, Danial ;
Barbera, Lisa ;
McGrail, Kim ;
Lawson, Beverley ;
Burge, Fred ;
Sutradhar, Rinku .
BMC PALLIATIVE CARE, 2018, 17
[29]   Current status of intensive end-of-life care in children with hematologic malignancy: a population-based study [J].
Yotani, Nobuyuki ;
Shinjo, Daisuke ;
Kato, Motohiro ;
Matsumoto, Kimikazu ;
Fushimi, Kiyohide ;
Kizawa, Yoshiyuki .
BMC PALLIATIVE CARE, 2021, 20 (01)
[30]   Rural versus urban differences in end-of-life care for lung cancer patients in Germany [J].
Walter, Julia ;
Tufman, Amanda ;
Leidl, Reiner ;
Holle, Rolf ;
Schwarzkopf, Larissa .
SUPPORTIVE CARE IN CANCER, 2018, 26 (07) :2275-2283